Cost-Utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients with Type 1 Hepatorenal Syndrome

ClinicoEconomics and Outcomes Research ◽

10.2147/ceor.s317390 ◽

2021 ◽

Vol Volume 13 ◽

pp. 703-715

Author(s):

Sermsiri Sangroongruangsri ◽

Kankamon Kittrongsiri ◽

Phunchai Charatcharoenwitthaya ◽

Abhasnee Sobhonslidsuk ◽

Usa Chaikledkaew

Keyword(s):

Hepatorenal Syndrome ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Type 1 Hepatorenal Syndrome

Download Full-text

Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility Analysis

Value in Health ◽

10.1016/j.jval.2017.05.021 ◽

2017 ◽

Vol 20 (10) ◽

pp. 1279-1287 ◽

Cited By ~ 4

Author(s):

Dalia Dawoud ◽

Elisabetta Fenu ◽

Bernard Higgins ◽

David Wonderling ◽

Stephanie A. Amiel

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Basal Insulin ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis

Download Full-text

PDB29 A COST-UTILITY ANALYSIS OF SODIUM-GLUCOSE COTRANSPORTER (SGLT) 2 INHIBITORS IN ADDITION TO BASAL-BOLUS INSULIN IN THE TREATMENT OF TYPE 1 DIABETES IN THE USA USING THE PRIME DIABETES MODEL

Value in Health ◽

10.1016/j.jval.2020.04.217 ◽

2020 ◽

Vol 23 ◽

pp. S113

Author(s):

R. Pollock ◽

W.J. Valentine

Keyword(s):

Type 1 Diabetes ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Sodium Glucose Cotransporter ◽

Diabetes Model ◽

The Usa ◽

Bolus Insulin ◽

Basal Bolus

Download Full-text

ND2 COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT

Value in Health ◽

10.1016/j.jval.2019.04.060 ◽

2019 ◽

Vol 22 ◽

pp. S42-S43 ◽

Cited By ~ 1

Author(s):

D. Malone ◽

R. Dean ◽

B. Miller ◽

R. Arjunji ◽

D.E. Feltner ◽

...

Keyword(s):

Single Dose ◽

Spinal Muscular Atrophy ◽

Muscular Atrophy ◽

Gene Replacement ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Spinal Muscular Atrophy Type ◽

Gene Replacement Therapy

Download Full-text

Cost-Utility Analysis of Continuous Infusion Pump With Integrated Monitoring Compared With Multiple Daily Injection Treatment for Patients 15-Years or Older With Type 1 Diabetes Mellitus In Colombia

Value in Health ◽

10.1016/j.jval.2015.09.693 ◽

2015 ◽

Vol 18 (7) ◽

pp. A360

Author(s):

H Quitian ◽

AM Gomez ◽

AA Garcia Peña ◽

J Arciniegas ◽

N Iragorri ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Infusion Pump ◽

Cost Utility ◽

Cost Utility Analysis ◽

Daily Injection ◽

Utility Analysis ◽

Integrated Monitoring ◽

Multiple Daily Injection

Download Full-text

Cost-Utility analysis of Insulin Degludec vs. Insulin Glargine U100 Treatment in Patients with Diabetes Mellitus type 1 and 2 in Serbia

Value in Health ◽

10.1016/j.jval.2016.09.1885 ◽

2016 ◽

Vol 19 (7) ◽

pp. A674-A675

Author(s):

M Culic ◽

M Russel-Szymczyk ◽

B Chubb ◽

C Tikkanen

Keyword(s):

Diabetes Mellitus ◽

Insulin Glargine ◽

Diabetes Mellitus Type 1 ◽

Cost Utility ◽

Cost Utility Analysis ◽

Insulin Degludec ◽

Diabetes Mellitus Type ◽

Utility Analysis ◽

Patients With Diabetes

Download Full-text

PDB21 A COST-UTILITY ANALYSIS OF INSULIN GLARGINE (LANTUS®) IN THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES

Value in Health ◽

10.1016/s1098-3015(10)61744-5 ◽

2003 ◽

Vol 6 (6) ◽

pp. 682

Author(s):

FK Kristensen ◽

JM Sverre ◽

S Bustad

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis

Download Full-text

PMD41 Insulin Pump Cost-Utility Analysis Compared to Multiple Daily Injection in Type 1 Diabetic Patients in the Mexican Social Security Institute, 21St Century Hospital

Value in Health ◽

10.1016/j.jval.2012.03.381 ◽

2012 ◽

Vol 15 (4) ◽

pp. A69

Author(s):

M. Quiroz ◽

F. Machado ◽

J. Shafiroff ◽

M. Gill ◽

M. Molina ◽

...

Keyword(s):

Insulin Pump ◽

Cost Utility ◽

Cost Utility Analysis ◽

Daily Injection ◽

Diabetic Patients ◽

Utility Analysis ◽

Multiple Daily Injection ◽

Type 1 Diabetic Patients ◽

Social Security Institute

Download Full-text

A short-term cost-utility analysis of insulin degludec versus insulin glargine U100 in patients with type 1 or type 2 diabetes in Denmark

Journal of Medical Economics ◽

10.1080/13696998.2016.1245663 ◽

2016 ◽

Vol 20 (3) ◽

pp. 213-220 ◽

Cited By ~ 8

Author(s):

R. F. Pollock ◽

C. K. Tikkanen

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Cost Utility ◽

Cost Utility Analysis ◽

Insulin Degludec ◽

Utility Analysis ◽

Short Term

Download Full-text

Basal Insulin Regimens: Systematic Review, Network Meta-Analysis, and Cost - Utility Analysis for the National Institute For Health and Care Excellence (Nice) Clinical Guideline on Type 1 Diabetes Mellitus in Adults

Value in Health ◽

10.1016/j.jval.2015.09.136 ◽

2015 ◽

Vol 18 (7) ◽

pp. A339 ◽

Cited By ~ 1

Author(s):

D Dawoud ◽

E Fenu ◽

D Wonderling ◽

R O’Mahony ◽

N Pursey ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 1 Diabetes ◽

Clinical Guideline ◽

Meta Analysis ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Nice Clinical Guideline

Download Full-text

PMU36 COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT IN JAPAN

Value in Health ◽

10.1016/j.jval.2020.04.810 ◽

2020 ◽

Vol 23 ◽

pp. S239

Author(s):

R. Dean ◽

B. Miller ◽

R. Arjunji ◽

H. Awano ◽

A. Igarashi ◽

...

Keyword(s):

Single Dose ◽

Spinal Muscular Atrophy ◽

Muscular Atrophy ◽

Gene Replacement ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Spinal Muscular Atrophy Type ◽

Gene Replacement Therapy

Download Full-text